Shandong Buchang Pharmaceuticals (603858.SH) has spent 528 million yuan to repurchase 3.03% of its shares.
BuXiang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has completed the central competitive bidding...
Shandong Buchang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has repurchased a total of 33.5555 million shares through centralized bidding trading. The repurchased shares account for 3.03% of the company's total share capital. The highest purchase price was 17.44 yuan per share and the lowest purchase price was 14.16 yuan per share. The total amount paid for the repurchases so far is 528 million yuan (excluding transaction fees).
Related Articles

EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?
EB SECURITIES: Shanghai Electric Group (02727) continues to make breakthroughs in emerging industries such as 25 years of nuclear fusion and Siasun Robot & Automation. We maintain a "buy" rating.

Guosheng Macro: Jobs in the United States show signs of improvement in March, but underlying worries remain.

Industrial: Market fluctuations intensify. How are various types of funds moving?

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


